144 related articles for article (PubMed ID: 31942199)
1. MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L.
Li X; Li Y; Jiang C; Chen L; Gan N
J Cancer; 2020; 11(3):759-768. PubMed ID: 31942199
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.
Cao M; Tian K; Sun W; Xu J; Tang Y; Wu S
Exp Ther Med; 2022 Jan; 23(1):97. PubMed ID: 34976139
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-363-3p inhibits tumor cell proliferation and invasion in oral squamous cell carcinoma cell lines by targeting SSFA2.
Zhu L; Zhang L; Tang Y; Zhang F; Wan C; Xu L; Guo P
Exp Ther Med; 2021 Jun; 21(6):549. PubMed ID: 33850521
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
Tan J; Xiang L; Xu G
IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.
Song X; Jin Y; Yan M; Zhang Y; Chen B
Oncol Lett; 2019 Jan; 17(1):688-696. PubMed ID: 30655818
[TBL] [Abstract][Full Text] [Related]
6. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.
Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K
Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208
[TBL] [Abstract][Full Text] [Related]
7. miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Pathol Res Pract; 2019 Apr; 215(4):660-667. PubMed ID: 30606659
[TBL] [Abstract][Full Text] [Related]
8. miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.
Yang X; Ruan H; Hu X; Cao A; Song L
Am J Cancer Res; 2017; 7(4):913-922. PubMed ID: 28469963
[TBL] [Abstract][Full Text] [Related]
9. Possible Role of miR-375-3p in Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma.
Saika M; Nakashiro KI; Tokuzen N; Shirai H; Uchida D
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672573
[TBL] [Abstract][Full Text] [Related]
10. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
11. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
13. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
14. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma.
Lu Y; Li Y; Wang Z; Xie S; Wang Q; Lei X; Ruan Y; Li J
Biomed Pharmacother; 2019 Apr; 112():108608. PubMed ID: 30798120
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-based miRNA delivery strategy inspired by the circCPNE1/miR-330-3p pathway for oral squamous cell carcinoma.
Fan HY; Zhao MD; Jiang HJ; Yu ZW; Fan YJ; Liang XH; Tang YL; Sun Y
Acta Pharm Sin B; 2024 Jun; 14(6):2748-2760. PubMed ID: 38828155
[TBL] [Abstract][Full Text] [Related]
20. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
